Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases

Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. The post Novo Nordisk Bets $200M on Triple-Targeting Drug for…

Read More

What to Know About How Medicare Pays Physicians

In November 2024, CMS finalized a 2.83% decrease in the physician fee schedule conversion factor, a key aspect of payment rates under the Medicare program, resulting in a 2.93% decrease in overall payments to physicians and other clinicians. Congress has not yet enacted legislation to address this payment cut, which went into effect on January…

Read More

Cómo afecta a todos los recortes de personal y dinero en las agencias de salud pública

En un soleado día de semana en Atlanta, un pequeño grupo de personas se reunió para realizar una manifestación frente a la sede de un sindicato. Al evento, organizado por Nikema Williams, representante demócrata en el Congreso nacional, asistieron miembros del sindicato y también trabajadores federales recientemente despedidos, entre ellos Ryan Sloane. “Me despidieron a…

Read More

Indiana Biomedical Society Named Association of the Month

The Indiana Biomedical Society (IBS) was recently recognized as TechNation’s Association of the Month for its commitment to supporting biomedical professionals across the state. Leading the organization is Naka Piohia, Crothall HTS Director at Marion General Hospital, who serves as IBS President. Founded in 1990, IBS provides a platform for professional development, networking, and industry…

Read More

En Colorado, comienzan a usar hongos psicódelicos para experimentación terapéutica

BOULDER, Colorado — Los organismos reguladores de Colorado están emitiendo licencias que permiten suministrar hongos psicodélicos con fines terapéuticos. A fines de la primavera o principios del verano es posible que ya estén autorizados los primeros “centros de sanación” estatales, donde se podrán consumir los hongos bajo supervisión. Esto ocurre casi dos años después de…

Read More

The Colorado Psychedelic Mushroom Experiment Has Arrived

BOULDER, Colo. — Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers,” where the mushrooms can be ingested under supervision, in late spring or early summer. The dawn of state-regulated psychedelic mushrooms has arrived in Colorado, nearly two years since Oregon began offering them. The…

Read More